ESPR Message Board Post 46311550 | Esperion Therapeutics...
home / stock / espr / espr message board
AviseAnalytics
()
Posted on: Jul/15/2024 09:26:15
ESPERION: REVOLUTIONIZING THE PHARMA INDUSTRY
$ESPR
Excited to share an article about Esperion Therapeutics Inc. (NASDAQ: ESPR), a pharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients with elevated low-density lipoprotein cholesterol (LDL-C).
Esperion has introduced the first oral non-statin LDL-C lowering therapy in 20 years, targeting a large market with high unmet needs. The company has received approval and an expanded label from the FDA for two drugs. Additionally, it has reported a 467% increase in total revenues for Q1 FY24 and a 54% increase for FY23, showing the potential for exponential growth. This makes it an intriguing opportunity to watch.
https://www.aviseanalytics.com/esperion-revolutionizing-the-pharma-industry/
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
Market:
Esperion Therapeutics Inc. Website:
-
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...
-
– OMERS Life Sciences to Purchase Esperion’s European Royalty on Bempedoic Acid Products for $304.7 Million with European Royalties Reverting to Esperion Once OMERS Receives 1.7 Times its Investment – – Esperion Retains Rights to Receive all Poten...